These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32776141)

  • 1. Antimicrobial Activity of Poly-epsilon-lysine Peptide Hydrogels Against Pseudomonas aeruginosa.
    Kennedy SM; Deshpande P; Gallagher AG; Horsburgh MJ; Allison HE; Kaye SB; Wellings DA; Williams RL
    Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):18. PubMed ID: 32776141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amoebicidal Activity of Poly-Epsilon-Lysine Functionalized Hydrogels.
    Kennedy SM; Deshpande P; Gallagher AG; Horsburgh MJ; Allison HE; Kaye SB; Wellings DA; Williams RL
    Invest Ophthalmol Vis Sci; 2022 Jan; 63(1):11. PubMed ID: 34994769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing a Porcine Ex Vivo Cornea Model for Studying Drug Treatments against Bacterial Keratitis.
    Okurowska K; Roy S; Thokala P; Partridge L; Garg P; MacNeil S; Monk PN; Karunakaran E
    J Vis Exp; 2020 May; (159):. PubMed ID: 32478743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-chlorotaurine and its analogues N,N-dichloro-2,2-dimethyltaurine and N-monochloro-2,2-dimethyltaurine are safe and effective bactericidal agents in ex vivo corneal infection models.
    Teuchner B; Eitzinger C; Lutz M; Hager T; Schmid E; Bechrakis NE; Zuck M; Jekle A; Debabov D; Anderson M; Nagl M
    Acta Ophthalmol; 2012 Dec; 90(8):e632-7. PubMed ID: 22971221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.
    Mannis MJ
    Trans Am Ophthalmol Soc; 2002; 100():243-71. PubMed ID: 12545697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel murine model for contact lens wear reveals clandestine IL-1R dependent corneal parainflammation and susceptibility to microbial keratitis upon inoculation with Pseudomonas aeruginosa.
    Metruccio MME; Wan SJ; Horneman H; Kroken AR; Sullivan AB; Truong TN; Mun JJ; Tam CKP; Frith R; Welsh L; George MD; Morris CA; Evans DJ; Fleiszig SMJ
    Ocul Surf; 2019 Jan; 17(1):119-133. PubMed ID: 30439473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis.
    Thibodeaux BA; Dajcs JJ; Caballero AR; Marquart ME; Girgis DO; O'Callaghan RJ
    Curr Eye Res; 2004 May; 28(5):337-42. PubMed ID: 15287370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel, Broad-Spectrum Antimicrobial Combination for the Treatment of Pseudomonas aeruginosa Corneal Infections.
    Chojnacki M; Philbrick A; Scherzi T; Pecora N; Dunman PM; Wozniak RAF
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial Blue Light Therapy for Infectious Keratitis: Ex Vivo and In Vivo Studies.
    Zhu H; Kochevar IE; Behlau I; Zhao J; Wang F; Wang Y; Sun X; Hamblin MR; Dai T
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):586-593. PubMed ID: 28129422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo challenging of polymyxins and levofloxacin eye drop against multidrug-resistant Pseudomonas aeruginosa keratitis.
    Tajima K; Miyake T; Koike N; Hattori T; Kumakura S; Yamaguchi T; Matsumoto T; Fujita K; Kuroda M; Ito N; Goto H
    J Infect Chemother; 2014 Jun; 20(6):343-9. PubMed ID: 24726376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Broad-Spectrum Antimicrobial Combination for the Treatment of Staphylococcus aureus and Pseudomonas aeruginosa Corneal Infections.
    Chojnacki M; Philbrick A; Wucher B; Reed JN; Tomaras A; Dunman PM; Wozniak RAF
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30420484
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of novel ciprofloxacin-releasing silicone hydrogel contact lenses.
    Hui A; Willcox M; Jones L
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4896-904. PubMed ID: 25028363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melimine-Coated Antimicrobial Contact Lenses Reduce Microbial Keratitis in an Animal Model.
    Dutta D; Vijay AK; Kumar N; Willcox MD
    Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5616-5624. PubMed ID: 27768798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa keratitis in an atopic silicone hydrogel lens wearer with rosacea.
    Robertson DM; Cavanagh HD
    Eye Contact Lens; 2005 Nov; 31(6):254-6. PubMed ID: 16284503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iontophoretic treatment of experimental pseudomonas keratitis in rabbit eyes using gentamicin-loaded hydrogels.
    Frucht-Pery J; Raiskup F; Mechoulam H; Shapiro M; Eljarrat-Binstock E; Domb A
    Cornea; 2006 Dec; 25(10):1182-6. PubMed ID: 17172895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two Different Concentrations of Topical Levofloxacin for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Keratitis.
    Tajima K; Miyake T; Koike N; Hattori T; Takahashi H; Matsumoto T; Fujita K; Kuroda M; Ito N; Goto H
    J Ocul Pharmacol Ther; 2015 Dec; 31(10):636-41. PubMed ID: 26348840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas aeruginosa MucD protease mediates keratitis by inhibiting neutrophil recruitment and promoting bacterial survival.
    Mochizuki Y; Suzuki T; Oka N; Zhang Y; Hayashi Y; Hayashi N; Gotoh N; Ohashi Y
    Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):240-6. PubMed ID: 24255043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of mupirocin and polymyxin B in experimental Staphylococcus aureus, Pseudomonas aeruginosa, and Serratia marcescens keratitis.
    Moreau JM; Conerly LL; Hume EB; Dajcs JJ; Girgis DO; Cannon BM; Thibodeaux BA; Stroman DW; O'Callaghan RJ
    Cornea; 2002 Nov; 21(8):807-11. PubMed ID: 12410042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of corneal collagen shields as a drug delivery device for the treatment of experimental Pseudomonas keratitis.
    Silbiger J; Stern GA
    Ophthalmology; 1992 Jun; 99(6):889-92. PubMed ID: 1630778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.